Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions

NCT02322619 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Moxifloxacin Tablets 400 mg

Sponsor

Dr. Reddy's Laboratories Limited